Publication: Sentinel Node Biopsy Imaging in Breast Cancer: Scatter Reduction Using 3-Dimensionally Printed Lead Shields.
Loading...
Identifiers
Date
2022-05-19
Authors
Cañete-Sánchez, Francisco M
Boulvard-Chollet, Xavier L E
Chamorro, Xabier
Marrodán MArch, Pablo Javier
Garrastachu Zumarán, Puy
Ramírez Lasanta, Rafael
Colletti, Patrick M
Giammarile, Francesco
Delgado Bolton, Roberto C
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Point of injection scatter (SPI) confounds breast cancer sentinel lymph node detection. Round flat lead shields (FLSs) incompletely reduce SPI, requiring repositioning. We designed lead shields that reduce SPI and acquisition time. Two concave lead shields, a semioval lead shield (OLS) and a semispherical lead alloy shield (SLS), were created with a SICNOVA JCR 1000 3D printer to cover the point of injection (patent no. ES1219895U). Twenty breast cancer patients had anterior and anterior oblique imaging, 5 minutes and 2 hours after a single 111 MBq nanocolloid in 0.2 mL intratumoral or periareolar injection. Each acquisition was 2 minutes. Absolute and normalized background corrected scatter counts (CSCs) and scatter reduction percentage (%SR) related to the FLS were calculated. Repositionings were recorded. Differences between means of %SR (t test) and between means of CSC (analysis of variance) with Holm multiple comparison tests were determined. Mean %SR was 91.8% with OLS and 92% using SLS in early images (P = 0.91) and 87.2%SR in OLS and 88.5% in late images (P = 0.66). There were significant differences between CSC using FLS and OLS (P We designed 2 concave lead shields that significantly reduce the SPI and repositioning with sentinel lymph node lymphoscintigraphy.
Description
MeSH Terms
Breast Neoplasms
Female
Humans
Lymph Nodes
Lymphatic Metastasis
Radionuclide Imaging
Radiopharmaceuticals
Sentinel Lymph Node Biopsy
Female
Humans
Lymph Nodes
Lymphatic Metastasis
Radionuclide Imaging
Radiopharmaceuticals
Sentinel Lymph Node Biopsy